About | Free Trial

Last Update

2016-07-25T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Curtis Cooper?

Dr. Curtis Cooper L.

Infectious Disease Specialist

The Ottawa Hospital

Direct Phone: (613) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The Ottawa Hospital

1053 Carling Ave.

Ottawa, Ontario K1Y 4E9

Canada

Company Description

The Ottawa Hospital is a compassionate provider of patient-centred care with an emphasis on tertiary-level and specialty care, primarily for residents of Eastern Ontario. The Ottawa Hospital educates future health-care professionals in partnership with th ... more

Find other employees at this company (6,361)

Background Information

Employment History

Associate Professor of Medicine

University of Ottawa

Affiliations

Scientific Steering Committee Member
Ontario HIV Treatment Network

Executive Board Member
Canadian Association for HIV Research

Education

MD

MD

University of Saskatchewan

medical degree

University of Saskatchewan

Web References (147 Total References)


Curtis Cooper, MD, ...

www.newevidence.com [cached]

Curtis Cooper, MD, FRCPC Dr. Cooper trained at the University of Saskatchewan, receiving his medical degree in 1994. He received certifications in Internal Medicine in 1997 and in Infectious Diseases in 1999 while at the University of Manitoba. He completed an HIV Research Fellowship and a master's degree in Epidemiology in 2002 at the University of Ottawa. Dr. Cooper's current titles include Associate Professor with the University of Ottawa, Scientist with the Ottawa Hospital Research Institute, Infectious Diseases Consultant with the Ottawa Hospital Division of Infectious Diseases, and Director of The Ottawa Hospital Viral Hepatitis Program, and he holds an Applied HIV Research Chair with the Ontario HIV Treatment Network (OHTN). Dr. Cooper is also co-chair of the CIHR Canadian HIV Trials Network Co-infection and Concurrent Diseases Research Core and an executive board member of the Canadian Association of HIV Researchers. As a clinical researcher, his research activities encompass viral hepatitis, HIV, and vaccine development with over 175 publications. His work is focused on the development of new therapeutic agents and the delivery of treatment that maximizes safety and adherence. He is an active researcher with several HCV and HIV cohort studies, including the Canadian Observational Cohort (CANOC) and the OHTN Cohort Study.


An interview with Dr. Curtis ...

www.newevidence.com [cached]

An interview with Dr. Curtis Cooper discussing the treatment of HCV with ledipasvir/sofosbuvir in the ION trials

...
Curtis Cooper, MD, FRCPC Dr. Cooper trained at the University of Saskatchewan, receiving his medical degree in 1994. He received certifications in Internal Medicine in 1997 and in Infectious Diseases in 1999 while at the University of Manitoba. He completed an HIV Research Fellowship and a master's degree in Epidemiology in 2002 at the University of Ottawa. Dr. Cooper's current titles include Associate Professor with the University of Ottawa, Scientist with the Ottawa Hospital Research Institute, Infectious Diseases Consultant with the Ottawa Hospital Division of Infectious Diseases, and Director of The Ottawa Hospital Viral Hepatitis Program, and he holds an Applied HIV Research Chair with the Ontario HIV Treatment Network (OHTN). Dr. Cooper is also co-chair of the CIHR Canadian HIV Trials Network Co-infection and Concurrent Diseases Research Core and an executive board member of the Canadian Association of HIV Researchers. As a clinical researcher, his research activities encompass viral hepatitis, HIV, and vaccine development with over 175 publications. His work is focused on the development of new therapeutic agents and the delivery of treatment that maximizes safety and adherence. He is an active researcher with several HCV and HIV cohort studies, including the Canadian Observational Cohort (CANOC) and the OHTN Cohort Study.


Curtis ...

www.ohtn.on.ca [cached]

Curtis Cooper

OHTN Applied HIV Research Chair
...
Curtis Cooper studies the optimum treatment and care of people living with Hepatitis C (HCV) and Hepatitis C/HIV co-infection (HIV/HCV)
Research Findings Curtis Cooper has had an important role in developing and evaluating the use of treatment regimens that do not contain interferon for the treatment of HCV, and continues to work towards the broader application of these therapies. Part of an international team of researchers who documented the barriers to the consistent use of HIV antiviral therapy. Their work showed similar challenges in many different settings in both the developed and developing world.
Curtis Cooper's research publications
Current Projects
...
Curtis Cooper is an Associate Professor of Medicine at the University of Ottawa and an Infectious Disease Specialist at The Ottawa Hospital where he works with a large practice of people living with Hepatitis C and Hepatitis C/HIV co-infection. He is working with other clinician scientists to develop new Canadian HIV/HCV treatment guidelines.
Curtis Cooper is a leader of the Canadian Observational Cohort (CANOC), and works with the CIHR CTN HIV-HCV Co-Infection Cohort, and the OHTN Cohort Study (OCS) in addition to maintaining his own viral hepatitis and HIV clinic cohorts. He continues to work to support and expand these cohorts and to foster collaboration between them to better understand issues in HIV/HCV care, and to increase the participation of Indigenous people and other at-risk populations in this research. He collaborates extensively with other OHTN clinical researchers including Sharon Walmsley and Janet Raboud.
OHTN Support:
Curtis Cooper holds an OHTN Applied HIV Research Chair focused on research to improve HIV/HCV care ($750,000; 2013-20180. First funded by OHTN in 2002.


Leadership & Members | Department of Medicine in Ottawa

thinkottawamedicine.ca [cached]

Curtis Cooper

...
Curtis Cooper


Previously, therapies for those with ...

thinkottawamedicine.ca [cached]

Previously, therapies for those with hepatitis C were "difficult" with "really serious side effects," such as fatigue, weight loss, headaches, poor sleep and mental health issues, said Dr. Curtis Cooper, the director of Ottawa Hospital and Regional Hepatitis Program, in a phone interview with Yahoo Canada. On top of the side effects, the treatments required injections for a period of 24 to 48 weeks.

Similar Profiles

Other People with this Name

Other people with the name Cooper

Jesanna Cooper
BirthWell Partners

Clyde Cooper
Re/max Allegiance

Jed Cooper
Jed

Michael Cooper
National Renal Administrators Association

Stephen Cooper
First State Investments Limited

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory